IMAX (IMAX) to Release Earnings on Thursday

Key Points

• IMAX is set to release its Q3 2025 earnings on October 23, 2025, with analysts expecting earnings of $0.31 per share and revenue of $102.88 million.
• The company previously reported Q2 2025 earnings of $0.26 per share, surpassing the consensus estimate, and its revenue increased by 3.1% year-over-year.
• Recent analyst ratings for IMAX include a "strong-buy" from Wall Street Zen, along with price target increases from Wells Fargo and JPMorgan, indicating a positive outlook for the stock.

IMAX (NYSE:IMAX - Get Free Report) will likely be posting its Q3 2025 results before the market opens on Thursday, October 23rd. Analysts expect IMAX to post earnings of $0.31 per share and revenue of $102.88 million for the quarter. Individuals may visit the the company's upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, October 23, 2025 at 8:30 AM ET.

IMAX (NYSE:IMAX - Get Free Report) last posted its earnings results on Thursday, July 24th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.07. IMAX had a net margin of 9.04% and a return on equity of 8.62%. The firm had revenue of $91.68 million during the quarter, compared to the consensus estimate of $93.04 million. During the same quarter last year, the firm earned $0.18 EPS. The firm's revenue for the quarter was up 3.1% on a year-over-year basis. On average, analysts expect IMAX to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

IMAX Stock Performance

IMAX stock opened at $31.69 on Thursday. IMAX has a fifty-two week low of $19.91 and a fifty-two week high of $34.14. The firm has a 50 day moving average price of $29.94 and a 200 day moving average price of $27.48. The company has a market capitalization of $1.70 billion, a PE ratio of 52.81, a price-to-earnings-growth ratio of 2.01 and a beta of 0.62.

Insider Buying and Selling at IMAX

In other news, VP Robert D. Lister sold 20,000 shares of IMAX stock in a transaction on Monday, September 15th. The shares were sold at an average price of $32.80, for a total transaction of $656,000.00. Following the completion of the sale, the vice president directly owned 161,421 shares of the company's stock, valued at approximately $5,294,608.80. The trade was a 11.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kenneth Ian Weissman sold 15,072 shares of IMAX stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $25.65, for a total transaction of $386,596.80. Following the sale, the insider directly owned 26,133 shares of the company's stock, valued at approximately $670,311.45. This trade represents a 36.58% decrease in their ownership of the stock. The disclosure for this sale can be found here. 23.18% of the stock is currently owned by insiders.

Institutional Investors Weigh In On IMAX

Several institutional investors have recently modified their holdings of IMAX. Orbis Allan Gray Ltd lifted its position in shares of IMAX by 31.7% during the 2nd quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company's stock worth $142,960,000 after purchasing an additional 1,230,267 shares during the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of IMAX during the 2nd quarter worth $12,568,000. Squarepoint Ops LLC lifted its position in IMAX by 177.0% in the second quarter. Squarepoint Ops LLC now owns 446,286 shares of the company's stock valued at $12,478,000 after acquiring an additional 285,184 shares during the last quarter. Nantahala Capital Management LLC lifted its position in IMAX by 24.9% in the second quarter. Nantahala Capital Management LLC now owns 1,133,993 shares of the company's stock valued at $31,706,000 after acquiring an additional 225,742 shares during the last quarter. Finally, Gabelli Funds LLC lifted its position in IMAX by 320.4% in the second quarter. Gabelli Funds LLC now owns 92,482 shares of the company's stock valued at $2,586,000 after acquiring an additional 70,482 shares during the last quarter. 93.51% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on IMAX. Weiss Ratings reissued a "hold (c+)" rating on shares of IMAX in a research report on Wednesday, October 8th. Wells Fargo & Company raised their price target on shares of IMAX from $30.00 to $34.00 and gave the company an "overweight" rating in a research report on Friday, July 25th. B. Riley reissued a "buy" rating on shares of IMAX in a research report on Friday, October 10th. Wall Street Zen raised shares of IMAX from a "buy" rating to a "strong-buy" rating in a research report on Saturday, October 11th. Finally, JPMorgan Chase & Co. raised their price target on shares of IMAX from $28.00 to $31.00 and gave the company a "neutral" rating in a research report on Thursday, October 9th. Nine research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, IMAX presently has an average rating of "Moderate Buy" and a consensus price target of $35.10.

IMAX Company Profile

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.